Bladder cancer symptoms often go unnoticed until it's too late. Learn the warning signs most people ignore and how early ...

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

Patients with high-risk bladder cancer reported similar quality of life when treated with sasanlimab plus BCG versus BCG alone, new study data showed.

Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk factor, genetics and chemic ...

Discover a study revealing how chemotherapy-induced tumour pyroptosis reprograms fibroblasts, promoting chemoresistance in ...

Bladder Cancer is a disease where cancer cells form in the tissues of the bladder. More common in males than females over 55 years of age, the cancer is known to cause blood in urine, which is ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...

Bladder cancer articles from across Nature Portfolio Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in ...

The New Brunswick, N.J., pharmaceutical giant on Thursday said the application covers TAR-200 for the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle invasive ...

BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated the muscle layer—is one of the earliest forms of cancer ...